Discontinuation report ACT RIZATRIPTAN ODT

Last updated on 2018-10-22 History
Report ID 65188
Drug Identification Number 02374730
Brand name ACT RIZATRIPTAN ODT
Common or Proper name RIZATRIPTAN OD
Company Name ACTAVIS PHARMA COMPANY
Market Status CANCELLED POST MARKET
Active Ingredient(s) RIZATRIPTAN
Strength(s) 5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL
Packaging size 12
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-03-30
Remaining supply date 2018-03-30
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2018-10-22 French Compare
v1 2018-10-22 English Compare

Showing 1 to 2 of 2